论文部分内容阅读
我们曾于去年赴日考察脏器生化制药情况。为期两周、先后到过东京、足利、川崎、清水、静冈、名古屋、京都、大阪、神户等地、对日研化学、理化学药品、帝国脏器、清水制药、静冈脏器制药、天野制药、卫材、大藏制药等八个株式会社及其所属工厂和研究所进行了参观。对血管舒缓素、胰岛素、氨基酸、胰酶等生化药品进行了技术座谈和重点考察;在生产管理和有关贸易等方面也作了一些了解:还先后与罗
We went to Japan last year to inspect the situation of organ biochemical drugs. For two weeks, he has been to Tokyo, Ashikaga, Kawasaki, Shimizu, Shizuoka, Nagoya, Kyoto, Osaka, Kobe and other places, on the Japanese chemical, physical and chemical drugs, the Imperial Organ, Shimizu Pharmaceutical, Shizuoka Pharmaceutical, Amano Pharmacy, Eisai, Kansai Pharmaceutical Co., Ltd. and their affiliated factories and research institutes visited. On the blood kallikrein, insulin, amino acids, trypsin and other biochemical drugs for a technical discussion and focus on inspection; in production management and related trade also made some understanding: also has with Luo